|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A01N 33/16 | |
| A61K 31/655 |
| (11) | Number of the document | 2124547 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08729939.2 |
| Date of filing the European patent application | 2008-02-15 | |
| (97) | Date of publication of the European application | 2009-12-02 |
| (45) | Date of publication and mention of the grant of the patent | 2018-03-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/054046 |
| Date | 2008-02-15 |
| (87) | Number | WO 2008/101141 |
| Date | 2008-08-21 |
| (30) | Number | Date | Country code |
| 890236 P | 2007-02-16 | US | |
| 892552 P | 2007-03-02 | US | |
| 908205 P | 2007-03-27 | US | |
| 949347 P | 2007-07-12 | US | |
| 952289 P | 2007-07-27 | US | |
| 969192 P | 2007-08-31 | US | |
| 977216 P | 2007-10-03 | US |
| (72) |
ERICKSON-MILLER, Connie, Lynn, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | CANCER TREATMENT METHOD |
| CANCER TREATMENT METHOD |